Company Filing History:
Years Active: 2021-2025
Title: Innovations by Kathy Chiu in SARS-CoV-2 Detection
Introduction
Kathy Chiu is an accomplished inventor based in Irvine, CA (US). She has made significant contributions to the field of molecular biology, particularly in the detection of SARS-CoV-2. With a total of 2 patents, her work has been pivotal in advancing diagnostic techniques for Covid-19.
Latest Patents
Kathy's latest patents focus on polynucleotides for the amplification and detection of SARS-CoV-2. These patents disclose primers and probes that are essential for nucleic acid amplification testing (NAAT). They are designed to amplify and determine the presence of SARS-CoV-2 in test samples, aiding in the diagnosis of Covid-19. Specifically, her work describes primers and probes that bind to the N gene, ORF1ab, or E gene of the SARS-CoV-2 coronavirus. This technology utilizes loop-mediated isothermal amplification (LAMP) and molecular beacon hybridization for effective detection.
Career Highlights
Kathy Chiu is currently associated with Talis Biomedical Corporation, where she continues to innovate in the field of diagnostics. Her expertise and dedication have positioned her as a key player in the fight against infectious diseases.
Collaborations
Kathy collaborates with talented individuals such as Nadya Andini and Xuewen Jiang, contributing to a dynamic research environment that fosters innovation.
Conclusion
Kathy Chiu's contributions to the detection of SARS-CoV-2 through her innovative patents highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also plays a crucial role in public health.